Pharmaceuticals - Indian - Formulations
Particulars (in ₹ Cr.) | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
---|---|---|---|---|---|
Total Revenue | 207.35 | 148.04 | - | - | - |
Total Expenses | 163.05 | 132.95 | - | - | - |
Profit Before Tax | 44.29 | 15.09 | - | - | - |
Profit After Tax | 33.52 | 11.19 | - | - | - |
Operating Profit after Depreciation | 45 | 16.23 | - | - | - |
Particulars (in ₹ Cr.) | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
---|---|---|---|---|---|
Fixed Assets | 59.74 | 28.59 | - | - | - |
Total Non Current Assets | 73.55 | 40.02 | - | - | - |
Total Current Assets | 77.48 | 21.53 | - | - | - |
TOTAL ASSETS | 151.03 | 61.54 | - | - | - |
Total Shareholder's Fund | 125.80 | 36.52 | - | - | - |
Particulars (in ₹ Cr.) | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
---|---|---|---|---|---|
Net Cash from Operating Activities | 14.52 | 16.35 | - | - | - |
Net Cash used in Investing Activities | -33.10 | -18.49 | - | - | - |
Net Cash used in Financing Activities | 48 | -4.51 | - | - | - |
Particulars (in ₹ Cr.) | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
---|---|---|---|---|---|
Total Revenue | 330.85 | 206.18 | 147.94 | 136.87 | 95.17 |
Total Expenses | 236.93 | 161.65 | 132.77 | 122.69 | 87.46 |
Profit Before Tax | 93.92 | 44.53 | 15.17 | 14.19 | 7.72 |
Profit After Tax | 69.21 | 33.74 | 11.27 | 10.29 | 5.73 |
Operating Profit after Depreciation | 94.33 | 45.23 | 16.31 | 15.49 | 9.35 |
Particulars (in ₹ Cr.) | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
---|---|---|---|---|---|
Fixed Assets | 66.85 | 59.74 | 28.35 | 22.67 | 16.66 |
Total Non Current Assets | 76.55 | 73.55 | 39.51 | 23.06 | 17.12 |
Total Current Assets | 143.98 | 77.48 | 22.04 | 26.09 | 20.91 |
TOTAL ASSETS | 220.53 | 151.03 | 61.55 | 49.15 | 38.04 |
Total Shareholder's Fund | 192.25 | 125.80 | 36.56 | 23.95 | 13.73 |
Particulars (in ₹ Cr.) | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
---|---|---|---|---|---|
Net Cash from Operating Activities | 36.69 | 17.17 | 17.48 | 17.53 | 11.74 |
Net Cash used in Investing Activities | -18.05 | -57.23 | -19.64 | -8.47 | -5.97 |
Net Cash used in Financing Activities | -3.44 | 48 | -4.51 | -1.53 | -5.05 |
No data available
No data available
₹4.18/Share
Company | Price | Market Cap (in ₹ Cr) |
---|---|---|
Jeena Sikho Lifecare Ltd | ₹1,861.35 | ₹4,627.34 |
Sun Pharmaceuticals Industries Ltd | ₹1,745.25 | ₹4,18,743.94 |
Divis Laboratories Ltd | ₹5,733.60 | ₹1,52,209.07 |
Cipla Ltd | ₹1,458.15 | ₹1,17,762.24 |
Torrent Pharmaceuticals Ltd | ₹3,357.15 | ₹1,13,616.11 |
Mankind Pharma Ltd | ₹2,488.40 | ₹1,02,663.15 |
06 Nov 2024, 12:54 pm
24 Sep 2024, 05:45 pm
05 Aug 2024, 02:38 pm
29 Jul 2024, 05:12 pm
24 Jul 2024, 10:41 am